Full-dose Atorvastatin After Acute Coronary Syndrome (ACS) in Non-revascularisable Coronary Artery Disease (APRIRE)

This study has been terminated.
(Interim analysis showed significant effect in favour of full-dose atorvastatin.)
Sponsor:
Collaborator:
Associazione Nazionale Medici Cardiologi Ospedalieri, Sezione Lazio
Information provided by:
San Filippo Neri General Hospital
ClinicalTrials.gov Identifier:
NCT01187992
First received: August 24, 2010
Last updated: NA
Last verified: May 2010
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2007
  Primary Completion Date: March 2007 (Final data collection date for primary outcome measure)
Publications: